SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-19-000031
Filing Date
2019-09-25
Accepted
2019-09-25 16:15:19
Documents
14
Period of Report
2019-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K anab-92519x8k.htm   iXBRL 8-K 35840
  Complete submission text file 0001370053-19-000031.txt   182511

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20190924.xsd EX-101.SCH 4588
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20190924_cal.xml EX-101.CAL 624
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20190924_def.xml EX-101.DEF 1474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20190924_lab.xml EX-101.LAB 27263
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20190924_pre.xml EX-101.PRE 14114
9 EXTRACTED XBRL INSTANCE DOCUMENT anab-92519x8k_htm.xml XML 4385
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 191114385
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences